Checkpoint Therapeutics Announces Publication of Cosibelimab Pivotal Trial Results in the Journal for ImmunoTherapy of Cancer Cosibelimab is the first PD-L1–blocking antibody to demonstrate a robust, durable and clinically meaningful objective response, and a manageable safety profile, in patients with metastatic cutaneous...

AMERICAN SYSTEMS Wins $1.01 Billion Defense Information Systems Agency (DISA) Test and Evaluation Contract II (TEC-II) CHANTILLY, Va., Dec. 12, 2022 (GLOBE NEWSWIRE) -- AMERICAN SYSTEMS has won a competitive single award, indefinite-delivery/indefinite-quantity contract for test, evaluation, and certification...

Big Switch Networks’ Reinforces Commitment to the U.S. Government’s Data Center Network Modernization Initiatives SANTA CLARA, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Big Switch Networks®, the Cloud-First Networking company, in its efforts to expand its commitment to the U.S. Government, today announced it...